Cargando…
CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways
BACKGROUND: The role of CARM1 in tumors is inconsistent. It acts as an oncogene in most cancers but it inhibits the progression of liver and pancreatic cancers. CARM1 has recently been reported to regulate autophagy, but this function is also context-dependent. However, the effect of CARM1 on gastri...
Autores principales: | Yang, Suzhen, Zhang, Jing, Chen, Di, Cao, Jiayi, Zheng, Ying, Han, Yuying, Jin, Yirong, Wang, Shuhui, Wang, Ting, Ma, Lin, Luo, Tingting, Wang, Yan, Qin, Wen, Dong, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895580/ https://www.ncbi.nlm.nih.gov/pubmed/35246137 http://dx.doi.org/10.1186/s12935-022-02522-0 |
Ejemplares similares
-
CARM1 Regulates AMPK Signaling in Skeletal Muscle
por: Stouth, Derek W., et al.
Publicado: (2020) -
AMPK-ERK/CARM1 Signaling Pathways Affect Autophagy of Hepatic Cells in Samples of Liver Cancer Patients
por: Qin, Qiu-Fang, et al.
Publicado: (2019) -
TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway
por: Fang, Yuan, et al.
Publicado: (2017) -
Calycosin inhibited autophagy and oxidative stress in chronic kidney disease skeletal muscle atrophy by regulating AMPK/SKP2/CARM1 signalling pathway
por: Hu, Rong, et al.
Publicado: (2020) -
Re: CaRMS at 50
por: MacFarlane, Malcolm
Publicado: (2020)